Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation | Zendy

Nahal Mavaddat | Zendy; Andrea Roalfe | Zendy; Kate Fletcher | Zendy; Gregory Y.H. Lip | Zendy; Richard Hobbs | Zendy; David Fitzmaurice | Zendy; Jonathan Mant | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Warfarin Versus Aspirin for Prevention of Cognitive Decline in Atrial Fibrillation

Author(s) -

Nahal Mavaddat,

Andrea Roalfe,

Kate Fletcher,

Gregory Y.H. Lip,

Richard Hobbs,

David Fitzmaurice,

Jonathan Mant

Publication year - 2014

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.113.004009

Subject(s) - medicine , atrial fibrillation , warfarin , aspirin , stroke (engine) , randomized controlled trial , imputation (statistics) , confidence interval , cognitive decline , cardiology , dementia , missing data , mechanical engineering , disease , machine learning , computer science , engineering

Atrial fibrillation is associated with decline of cognitive function. Observational evidence suggests that anticoagulation might protect against this decline. We report the first randomized controlled trial evidence on the effect of anticoagulation on cognitive function in elderly patients with atrial fibrillation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research